The 8th CKD Summit 2026 is a definitive global forum for chronic kidney disease drug development, uniting pharma, biotech, clinicians, and academics to tackle unmet needs across the CKD pipeline.
This event guide explores advances in disease stratification, trial design, biomarkers, and patient-centric endpoints, alongside the strategic partnerships accelerating translation from bench to bedside.
Key themes include:
- CKD disease heterogeneity and patient stratification
- Clinical trial design and endpoint optimization
- Biomarkers and translational models
- Cross-sector collaboration and partnering strategies
About Hanson Wade Group - 8th CKD Summit 2026
Advance More Personalized & Efficacious Therapies to Transform the Standard of Care for Rare & Common Kidney Diseases
Uniting Renal Biotech & Pharma to Drive the Next Wave of CKD Drug Discovery, Translation & Clinical Innovation
With recent FDA approvals for Apellis’ pegcetacoplan for C3G and Novartis’ atrasentan for IgAN, the renal drug development space is entering a transformative era. Over 75 biopharma companies and over 80 pipeline drugs, including AstraZeneca, Eli Lilly, Boehringer Ingelheim, and Bayer, are doubling down on CKD R&D, driven by transcriptomic breakthroughs, novel endpoints like proteinuria and eGFR, and a surge in precision medicine strategies. The global CKD market is projected to exceed $110 billion by 2030, with landmark deals such as Novartis’ $1.7 B acquisition of Regulus Therapeutics underscoring the sector’s momentum.
Returning to Boston on March 16–18, 2026, the 8th CKD Drug Development Summit unites 150+ senior leaders across discovery, translational, clinical, regulatory, and commercial functions. Hear from 44+ expert speakers from over 35+ companies including Apellis Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Eli Lilly, Maze Therapeutics, Otsuka, Purespring Therapeutics, Takeda, Vertex Pharmaceuticals, and more. With dedicated tracks for preclinical and clinical innovation, plus a brand-new Polycystic Kidney Disease Focus Day and late-stage workshops on regulatory strategy and market access, the summit delivers three days of cutting-edge insights, strategic networking, and actionable takeaways to accelerate renal therapeutic innovation.
Download the Event Guide
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.